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DOI 10.1186/s12873-015-0028-3RESEARCH ARTICLE Open AccessPredictors for outcome among cardiac arrest
patients: the importance of initial cardiac arrest
rhythm versus time to return of spontaneous
circulation, a retrospective cohort study
Ida Wibrandt*†, Kristine Norsted†, Henrik Schmidt and Jens SchierbeckAbstract
Background: In the past decade, early treatment of cardiac arrest (CA) victims has been improved in several ways,
leading to more optimistic over all prognoses. However, the global survival rate after out-of-hospital CA (OHCA)
is still not more than 5-10%. With a better knowledge of the predictors for outcome among CA patients, we can
improve the management of CA, in order to strengthen the leads in the chain of survival.
Methods: A retrospective cohort study including 172 CA patients admitted to the intensive care unit (ICU) in
Odense University Hospital (OUH) in a three-year period was conducted. We determined the 90-day mortality and
neurological outcome at discharge for CA patients treated with therapeutic hypothermia (TH), in regard to determine
the importance of the predictors for mortality and neurological outcome, with emphasize on combining initial rhythm
and time to return of spontaneous circulation (ROSC).
Results: The overall mortality was 44% and a favorable neurological outcome was seen among 52%. Strong predictors
for survival and favorable neurological outcome were ventricular tachycardia/ventricular fibrillation (VT/VF) as initial
rhythm, cardiac etiology and time to ROSC < 20 minutes. Age < 60 years was a predictor for survival only. Patients with
the combination of VT/VF and ROSC < 20 minutes had undeniably the best chance of both survival and a favorable
neurological outcome.
Conclusions: We found significant predictors for both survival and neurological outcome, in which an initial rhythm of
VT/VF and a cardiac etiology were the strongest.Background
Cardiac arrest (CA) victims have a high risk of death or
poor neurologic function. The survival rate of out-of-
hospital CA (OHCA) is reported to be 5-10% [1,2].
However, survival rates can reach 20-40% in witnessed
cases of OHCA with VF as initial rhythm in communi-
ties where the chain of survival is strong [3,4]. It is
known that the most common initial rhythm is ventricu-
lar fibrillation (VF), with a frequency of 60-80% of all CA.
Because VF is a shockable rhythm, the chance of survival
is up to 10 times higher compared with the non-VT/VF
rhythms [5]. In Denmark, there is approximately 3500* Correspondence: ida.wibrandt@gmail.com
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unless otherwise stated.OHCA every year and the 30-day survival rate was 10.1%
in 2011. The median age for OHCA patients in Denmark
are 70 and 65% of the OHCA patients are males. Strong
predictors for 30-day survival are reported to be bystander
cardiopulmonary resuscitation (CPR) before the arrival of
the ambulance, early defibrillation, short time to return of
spontaneous circulation (ROSC) and VT/VF as initial
rhythm [4,6].
Therapeutic hypothermia (TH) may be beneficial in
treatment of patients achieving ROSC after CA [7-9].
The background for the current recommendations re-
garding TH is based on two randomized controlled trials
(RCT) published in 2002 [8,9], which demonstrated that
TH increases the rate of neurological recovery and re-
duces the mortality after CA. Based on the two articles,
the Advanced Life Support (ALS) Task Force of theal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in 2003 recommended TH for CA survivals [10] and the
treatment was, and still is, included in the European Resus-
citation Council Guidelines for resuscitation [11].
A large amount of studies have investigated different
outcome measures among CA patients treated with TH
and there are many reports on predictors for outcome.
Less is known about the importance of these predictors
against each other.
The aim of this retrospective analysis was to determine
the 90-day mortality and neurological outcome at discharge
for CA patients treated with TH, in regard to determine the
importance of the predictors for mortality and neurological
outcome, with emphasize on combining initial rhythm and
time to ROSC.Methods
Study design and patient population
We conducted a retrospective cohort study, where we
studied medical records of CA patients admitted to one
of the two ICUs in Odense University Hospital (OUH)
in Denmark between January 1st 2008 and December
31st 2010. The two ICUs followed the same protocol
regarding the management of CA patients.
The criteria for inclusion were:
1. Adults with an age ≥ 18 years, suffering from either
in-hospital CA (IHCA) or OHCA with ROSC,
regardless of initial rhythm or etiology. We allowed
the CA to be both witnessed and un-witnessed.
2. Treatment with TH.Data collection
Data was found in the internal database for medical
journals. Permission to use the database was given by
the management of the Department of Anesthesiology
and Intensive Care, OUH. The Regional Committees on
Health Research Ethics for Southern Denmark ruled that
no formal ethics approval was required in this case.
The following baseline characteristics were registered
from the medical records; age, gender, number of days alive,
mortality at discharge, 30 and 90 days, location of CA
(IHCA or OHCA), initial rhythm, time from collapse to
ROSC (<20 min. or ≥ 20 min.), etiology and discharge des-
tination (home/rehabilitation facility or nursing home/
death). We chose to register time to ROSC as < or ≥ 20 mi-
nutes, to make the results comparable with other studies in
the field [12-16]. We registered the first recorded rhythm
during CA as the initial rhythm. Favorable neurological
outcome was defined as a Cerebral Performance Category
(CPC) of 1–2 (discharge to home or rehabilitation facility)
and unfavorable neurological outcome was defined as CPC
3–5 (discharge to nursing home or death) [17].Outcome assessment
The primary outcomes were overall mortality at 90 days
from the CA and neurological outcome at discharge
from hospital. We compared the initial rhythm and the
time to ROSC as predictors for mortality and neuro-
logical outcome. Secondly, we investigated other predic-
tors for outcome.
Cooling
Cooling was initiated and maintained according to current
resuscitation guideline [18]. TH was initiated with infusion
of cold saline and ice packages in axilla and groin to a tar-
get temperature of 33°C and hypothermia was maintained
for 24 hours by a cooling dress. Passive rewarming was
performed with a temperature increase of 0.5°C per hour.
Statistical analysis
Statistical analyses were performed using GraphPad Prism®
version 5. Continuous data was expressed as mean ± stand-
ard deviation (SD) when visual inspection suggested nor-
mally distribution. When not normally distributed, results
were expressed as median and interquartile range. Categor-
ical variables were reported as counts and percentages. Bin-
ary categorical variables were compared using Chi-squared
test or Fisher’s exact test. Results were expressed as Odds
Ratio (OR) and 95% Confidence Interval (CI). A P-value <
0.05 was considered statistical significant and all tests were
two-sided.
Results
The study population consisted of 173 patients over the
age of 18. One patient was excluded from the study due
to foreign nationality and therefore lack of fundamental
information. Due to missing information in medical re-
cords; one patient had unknown initial rhythm, three pa-
tients had unknown time to ROSC and four patients had
unknown discharge destination. These patients were still
included in the study, although not in the analysis con-
cerning their missing data. Finally, 172 patients were en-
rolled (Table 1). The vast majority of the patients
admitted to the ICU after having CA with ROSC in the
study period received TH treatment. Only 7 patients did
not receive TH, they all suffered from severe instability
due to cardiogenic shock and died within a few hours.
Mortality
Among the entire patient population, there was an over-
all 90-day mortality rate of 44% (Figure 1). There was a
significant difference in mortality rates among the entire
patient population and patients with cardiac etiology
only (P = 0.0262). Patients with a cardiac etiology had a
90-day mortality rate of 30%, compared with non-
cardiac etiology; 78% (P < 0.0001). The 90-day mortality
rate for all patients, regardless of etiology, presenting
Table 1 Baseline characteristics
Characteristics Study group
Gender - no./total no. (%)
Male 131/172 (76)
Female 41/172 (24)
Age - year
Mean ± SD 60.0 ± 12.9
≤60 years - no./total no. (%) 83 (48)
>60 years - no./total no. (%) 89 (52)
Mortality at discharge - no./total no. (%) 76/172 (44)
Mortality at 30 days from - CA no./total no. (%) 73/172 (42)
Mortality at 90 days from CA - no./total no. (%) 76/172 (44)
Location of cardiac arrest - no./total no. (%)
Out-of-hospital 142/172 (83)
In hospital 30/172 (17)
VT/VF rhythm at presentation - no./total no.1 (%) 122/171 (71)
Non-VT/VF rhythm at presentation - no./total no. (%) 49/171 (29)
Asystole 41/171 (24)
Pulseless electrical activity (PEA) 4/171 (2.5)
Unknown non-shockable rhythm 4/171 (2.5)
Time from collapse to ROSC - no./total no.2 (%)
<20 minutes 117/169 (69)
≥20 minutes 52/169 (31)
Etiology of cardiac arrest - no./total no. (%)
Cardiac 124/172 (72)
Respiratory 28/172 (16)
Intoxication 7/172 (4)
Cerebral 3/172 (2)
Trauma 1/172 (0.5)
Malignant 1/172 (0.5)
Undefined 8/172 (5)
Discharge destination - no./total no.3 (%)
Home/Rehabilitation facility 88/168 (52)
Nursing home/Death 80/168 (48)
CA: Cardiac arrest. VT: Ventricular tachycardia. VF: Ventricular fibrillation. ROSC:
Return of Spontaneous Circulation.
1One patient data missing because of unknown initial rhythm.
2Three patients data missing because of unknown time to ROSC.
3Four patients data missing because of unknown discharge destination.
Figure 1 90-day mortality and etiology.
Figure 2 90-day mortality, time to ROSC and initial rhythm for
patients with cardiac etiology only. ROSC = Return of spontaneous
circulation. VT = Ventricular Tachycardia. VF = Ventricular Fibrillation.
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etiology (30%). For patients with cardiac etiology only,
the mortality rate for VT/VF and non-VT/VF was 21%
and 71% respectively (P < 0.0001).
Combining time to ROSC and initial rhythm revealed
that the initial rhythm was the strongest predictor for
survival. In Figure 2, the results of combining initial
rhythm with time to ROSC among CA patients with a
cardiac etiology can be seen. The mortality rate was 17%
for VT/VF and ROSC < 20 min. and 49% for VT/VF andROSC > 20 min. (P = 0.0004). It was 67% for non-VT/VF
and ROSC < 20 min. and 86% for non-VT/VF and
ROSC > 20 min. (P = 0.2362).
Survival was significantly better in younger patients.
Mortality rate for patients with cardiac etiology and
age ≤ or > 60 were 21% and 39% (P = 0.0325). Changing
the age limit to ≤ and > 70, the difference in mortality
was not significant, neither for all patients nor patients
with cardiac etiology only.
OHCA patients had a trend towards a lower mortality
than IHCA patients; 41% and 57% (P = 0.1055). There
was a higher rate of cardiac etiology among patients with
OHCA than IHCA, 80% and 37%.Neurological outcome
Among all 168 patients where neurological outcome
could be evaluated, 52% had a favorable outcome (CPC
1–2). Only 10 patients (6%) were discharged to rehabili-
tation facility or nursing home and had thereby a poor
neurologic outcome (CPC 3–4). Furthermore, 42% of
the patients evaluated for neurological outcome died
Wibrandt et al. BMC Emergency Medicine  (2015) 15:3 Page 4 of 7(CPC 5). 67% of patients with cardiac etiology had a
favorable outcome, compared with 17% of patients with
non-cardiac etiology (OR: 10.0; 95% CI, 4.28 to 23.4;
P < 0.0001).
The initial rhythm had a greater influence on the
neurological outcome than time to ROSC. Patients with
VT/VF had a significantly better outcome than patients
with non-VT/VF, regardless of time to ROSC. The un-
deniably highest rate of favorable neurological outcome
(83%) was seen among patients with cardiac etiology
with VT/VF and ROSC < 20 min. In the same subgroup
of patients, with ROSC > 20 min., the rate of favorable
outcome was 51% (P < 0.0001). In patients with non-VT/
VF and ROSC </> 20 min., the results were 33% and
14% respectively (Figure 3).
Age was not a predictor for a favorable neurological
outcome (P = 0.1309).
Initial rhythm related to other clinical factors
There was a considerably higher occurrence of cardiac
etiology among patients with VT/VF, than among pa-
tients with non-VT/VF; 91% and 29%, respectively (OR:
25.2; 95% CI, 10.5 to 60.6; P < 0.0001). There was no sig-
nificant difference in the distribution of time to ROSC
</≥ 20 minutes between VT/VF and non-VT/VF
rhythms (OR: 0.87; 95% CI, 0.42 to 1.80; P = 0.8543).
Furthermore, there was no significant difference in the oc-
currence of VT/VF and non-VT/VF rhythms in neither
age (P = 0.8665) nor gender (P = 0.1133).
Table 2 summarizes the predictors for survival and a
favorable neurological outcome.
Discussion
In this retrospective cohort study, we investigated mortality,
neurological outcome and possible predictors for favorable
outcome in CA patients over a 3-year period at a Danish
University Hospital. We investigated the importance ofFigure 3 Neurological outcome; time to ROSC and initial rhythm for p
circulation. VT = Ventricular Tachycardia. VF = Ventricular Fibrillation.having a shockable initial rhythm versus a low time to
ROSC for the mortality and neurological outcome. We
found that an initial rhythm of VT/VF, CA of cardiac eti-
ology, time to ROSC < 20 minutes and age < 60 years were
all predictors for survival. The initial rhythm had a greater
influence on the mortality and neurological outcome than
time to ROSC.
Mortality
The overall 90-day mortality was 44% and this is consist-
ent with results of similar studies [12,19-21]. The major-
ity of patients, who died, died within the first 20 days
after their CA. This confirms that if the patients live
through the first couple of weeks, they tend to survive.
Also, patients who have a poor pre-CA health status
and/or suffer from severe heart-/brain injury are likely
to die as a direct result of the CA.
The 90-day mortality rate decreases significantly in pa-
tients with cardiac etiology compared with non-cardiac
etiology, which illustrates that a cardiac cause is a pre-
dictor for good outcome. Our findings regarding a 90-
day mortality rate of 30% are comparable to the results
in the HACA study [9] and the study by Stub et al. [13].
The significant decrease in mortality in cardiac patients
can be explained by a more frequent occurrence of VT/
VF rhythms in these patients. We found that the odds of
having a VT/VF rhythm of cardiac etiology are 25 times the
odds of having a VT/VF rhythm of non-cardiac etiology.
The better prognosis for patients with cardiac etiology may
also be a result of more extended treatment options such as
coronary artery catheterization, cardiac surgery, prophylac-
tic Implantable Cardiac Defibrillator (ICD) therapy and
pharmacological treatment.
Patients with VT/VF had a significantly lower mortal-
ity rate than patients with non-VT/VF and our results
are consistent with the results of several other studies
[5,22,23]. It is known that VT/VF has a better prognosisatients with cardiac etiology. ROSC = Return of spontaneous
Table 2 Analysis of clinical predictors for survival and favorable neurological outcome
Survival Favorable neurological outcome
OR 95% CI P-value OR 95% CI P-value
VT/VF on presentation 9.32 4.20 – 20.70 <0.0001 12.5 5.13 – 30.40 <0.0001
Cardiac etiology 8.60 3.89 – 19.00 <0.0001 10.0 4.28 – 23.40 <0.0001
ROSC < 20 minutes 2.45 1.26 – 4.78 0.0115 2.16 1.10 – 4.24 0.0287
Age < 60 years 1.89 1.03 – 3.48 0.0466 1.60 0.88 – 2.92 0.1309
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perfusing rhythm. Also, VT/VF is associated with a
cardiac etiology.
Neurological outcome
The fact that only 10 out of 168 patients were dis-
charged to nursing home or rehabilitation facility indi-
cates that patients, who survive, are likely to return to
their previous neurological status. After the introduction
of TH treatment, studies have shown that the number of
CA patients discharged with a CPC score of 3–4 has de-
creased and correspondingly, the number of patients
with CPC 1–2 has increased [8,20,22]. This may be a
part of the explanation for the high number of patients
being discharged with an intact neurological status after
CA. Also, nowadays, in patients who are assessed as
being at high risk of either dying or ending up in a vege-
tative state, futile treatment is often terminated.
We have demonstrated that the odds of being discharged
with a favorable outcome are 10 times higher when having
a cardiac etiology than a non-cardiac etiology. 67% of pa-
tients with a cardiac etiology had a favorable outcome,
which is noticeably better than the findings by Bernard
et al. [8], which was 49%. This is in spite of the fact that
some of the patients in our study with cardiac etiology had
non-VT/VF rhythms and Bernard et al. only included
OHCA patients with VT/VF. One should though have in
mind that the study by Bernard et al. was conducted over
10 years ago and treatment methods, especially regarding
resuscitation, have been changed. First of all, in Denmark,
the use of mobile intensive care units (ambulances with
anesthesiologists and intensive care equipment) now allows
for immediate initiation of professional CPR and subse-
quent cooling. Secondly, medical personnel are nowadays
more experienced with TH treatment. Furthermore, our
study population was significantly larger than in the study
by Bernard et al. and the statistical certainty is therefore
stronger.
Our results demonstrate that 91% of patients with a car-
diac etiology present with VT/VF, which illustrates the
strong correlation between these two variables. Our results
regarding initial rhythm as a predictor for neurologic out-
come are consistent with prior studies [12,13,19,24,25].
When only investigating the patients with a cardiac eti-
ology, the odds of having a favorable neurological outcomewhen having a VT/VF rhythm are 8.6 times higher than the
odds of favorable outcome and non-VT/VF. It is important,
though, to be aware of the small number of patients with
cardiac etiology and non-VT/VF, which may lead to a stat-
istical uncertainty. Nevertheless, we can, based on our re-
sults, emphasize that a cardiac etiology and VT/VF have a
strong positive impact on the outcome for CA patients.
Time to ROSC associated with mortality and neurological
outcome
We have illustrated that time from collapse to ROSC< 20
minutes is a positive predictor for survival and neuro-
logical outcome. Similar results have been shown in
other studies [12,14,19]. When combining initial rhythm
and time to ROSC, a remarkable finding is that the initial
rhythm is the most important predictor for both survival
and neurological outcome. In other words, the duration of
non-sufficient circulation is not as important for survival
and neurological outcome as the initial cardiac arrest
rhythm. When having non-VT/VF, the time to ROSC is
insignificant for both survival and neurological outcome
in this study. Our results are verified by Herlitz et al. [22],
who demonstrated that initial rhythm is the strongest pre-
dictor for survival, followed by time from call for and
arrival of the ambulance, used as a marker for time to
ROSC. However, there is a possibility that the initial
rhythm itself can have an influence on time to ROSC,
since a shockable rhythm can often be defibrillated into a
perfusing rhythm. Our data describing mortality, initial
rhythm and time to ROSC, show a trend towards a lower
mortality among patients with cardiac etiology, but as the
number of patients in each subgroup is small, it is difficult
to draw any conclusions.
Age associated with mortality and neurological outcome
The association between age and prognosis has been incon-
clusive in previous studies. There is a trend towards a lower
mortality rate among younger patients [13,16,19,21,26] but
there are also studies, which have not found an association
between age and survival [12,27]. In our study, an age
under 60 is a positive predictor for survival, regardless
of etiology. Though, possible confounders should be con-
sidered, e.g. higher rate of comorbidities among elderly.
The occurrence of VT/VF and non-VT/VF is not associ-
ated with age, neither is etiology.
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showed no statistical significance of lower mortality among
patients < 70 years. Similar results are found in a Danish
study, conducted by Larsen et al. [28]. The fact that the
association between mortality and age </≥ 60 is statistically
significant, suggests that the mortality rates are high in the
group of patients between 60 and 70 years. Taking the
above-mentioned results into consideration, it is indicated
that active treatment of CA should not be excluded based
on age.
Location of CA associated with mortality and neurological
outcome
Higher mortality rates among patients who suffered from
IHCA compared with OHCA were also demonstrated in a
study by Meaney et al. [24]. We assume that IHCA patients
have a higher number of comorbidities and that they are
more vulnerable on the actual time of the CA, which can
lead to a selection bias in this study. The majority of IHCA
patients had a non-cardiac etiology, mainly hypoxia, and
therefore in higher risk of having a non-VT/VF rhythm and
a worse prognosis. However, we have shown that 37% of
the IHCA patients in this study suffered from CA of cardiac
etiology. We included both ICHA and OHCA patients in
this study, which of course may lead to a noticeable bias
taken different etiologies into consideration. However, in
our results, we analyze data from patients with cardiac and
non-cardiac etiology separately, which narrows this bias
considerably.
Therapeutic hypothermia
The findings by Bernard et al. and Holzer et al. [8,9], have
been further investigated and confirmed by other studies
[12,13,19-21,25]. However, a recent International RCT by
Nielsen et al. [29], reported no significant difference in
outcome between OHCA patients with presumed cardiac
cause, treated with hypothermia at a target temperature of
33°C versus 36°C, which led to the conclusion that the
main consequence of TH may be preventing fever. An-
other recent Norwegian multicenter study by Lindner et al.
[21], investigating prognostic factors for the use of TH in
OHCA survivals, showed that after correcting for other
prognostic factors, use of TH remained an independent
predictor of improved survival. Hence, the discussion on
whether or not TH is beneficial for outcome among CA pa-
tients is undoubtedly still on going.
TH does not appear to be associated with a higher
number of patients ending up in a vegetative state. This
may be influenced by the fact that the treatment of the
patients at risk is terminated. Either way, the concerning
patients are still treated with TH and are thereby given
the chance of neurological improvement. However, our
results are consistent with other studies, which report a
high mortality and unfavorable neurological outcome forpatients with non-VT/VF rhythms, regardless of treatment
method [24,25,27].
The future
In the past decade, the early treatment of CA victims has
been improved in several ways, leading to more optimistic
over all prognoses. A recent study by Wissenberg et al. [4],
revealed that the bystander CPR rate in Denmark have in-
creased significantly, from 21% in 2001 to 45% in 2010.
Also, 30 day survival improved from 3,5% in 2001 to 10,8%
in 2010. Although, because of co-occurrence of several ini-
tiatives to improve the management of OHCA patients in
this period, the conclusion that the increased bystander rate
is the main cause of the improved survival rate, cannot be
drawn. On the other hand, increased bystander rate is
highly correlated with the strong predictors of good out-
come in this study; initial rhythm and time to ROSC.
Limitations
There are several limitations to our study. We have con-
ducted a retrospective cohort study and it is therefore
subject to potential confounders and selection bias. Our
data is retrospectively collected from medical records,
leading to an information bias. Many of the investigated
parameters are interpreted from clinical notes, which
may have affected our results.
The patients comprise a selected group; all treated at a
university hospital which has extended treatment options
and personnel with extensive experience in managing pa-
tients with CA, indicating a selection bias. Also to be taken
into consideration as a weakness, is the statistical uncer-
tainty that occurs when several variables are compared,
resulting in smaller study populations.
The strengths in our study are the relatively large patient
population and the well-performed comparison between
the initial rhythm and time to ROSC. We present strong
statistical significance in well-defined tables.
Conclusions
Our study results support the results of prior studies
conducted on TH treated CA patients. 44% of all pa-
tients died and 52% of all patients were discharged with
a favorable outcome. Predictors for survival and a favor-
able neurological outcome were VT/VF as presenting
rhythm, CA of cardiac origin and time to ROSC < 20 mi-
nutes. Age < 60 years was a predictor for survival only.
There is a strong correlation between initial rhythm and
etiology. Together and individually, these parameters are
strong predictors for both survival and a favorable neuro-
logical outcome.
When combining initial rhythm and time to ROSC,
we found that the duration of non-sufficient circulation
during CA is not as important for survival and favorable
neurological outcome as an initial rhythm of VT/VF.
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